K2 / Spice Drug Test Guide: Panels, Detection Windows & More

Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated August 2026

Quick answer: Full cannabinoid-receptor agonists (indazole/indole families) — not included on the federal 5-panel. Urine detects it roughly 1–3 days typical; up to ~2 weeks chronic heavy use (lipophilic metabolites); hair archives ~90 days; saliva and blood track only recent use. Specialized immunoassays ~5–10 ng/mL target JWH/AM families; constant cat-and-mouse with new analogues.

Overview

This guide covers everything verifiable about how testing handles K2 / Spice (synthetic cannabinoids) (also searched as: spice, synthetic weed, incense, herbal incense): which panels include it, detection windows across specimens, cutoff levels, false-positive risks, and legitimate prescription handling.

Panel membership

PanelK2/Spice status
5-Panel❌ Not included
10-PanelRarely
12-PanelRarely
DOT 5-panel (safety-sensitive)❌ Not included

Detection windows

Ranges reflect occasional-to-heavy use patterns from FDA device inserts and SAMHSA-certified lab conventions.
Test typeTypical K2/Spice detection window
Urineany: 1–3 days typical; up to ~2 weeks chronic heavy use (lipophilic metabolites)
Saliva (Mouth Swab)any: 1–2 days
Hair Folliclesup to 90 days (specialized)
Bloodany: ~1–2 days

Cutoff levels

Specialized immunoassays ~5–10 ng/mL target JWH/AM families; constant cat-and-mouse with new analogues.

Cutoffs exist to separate real use from noise — dietary exposure, passive contact and legacy medications stay below them by design. Screen-above-cutoff results still require mass-spec confirmation before reporting.

Deep-dive facts

'Spice doesn't show up' is outdated: dedicated synthetic-cannabinoid strips exist on some 12-panel-plus cups, probation panels, and military programs. Coverage lags the chemistry — new analogues escape until assays update.

Military testing actively pursues spice after wave-of-hospitalizations incidents; service members should assume detection.

Legal status note

Schedule I (class-wide analogue acts).

Popular guides in this series

Certified labs nationwide · Results in 1–2 days

Need a test? Order online, test same-day →
Medical disclaimer: DrugPanels provides educational information about laboratory drug testing and does not offer medical advice, diagnosis, or treatment. Detection windows are population ranges — individual results vary with metabolism, dose, frequency and health status. Never stop prescribed medication to pass a test without talking to your prescriber. Affiliate disclosure: some links on this page are affiliate links; if you order through them we may earn a commission at no additional cost to you.

People also ask

Does K2 Come up on a Drug Test?

No — K2/Spice is absent from standard drug panels. Full guide →

How to Pass a Drug Test for K2?

Evidence-based ways to pass a drug test for K2/Spice — realistic timelines, what works, what backfires, and dilution flags to avoid. Full guide →

K2 / Spice Drug Test Guide: Panels, Detection Windows & More?

Complete K2/Spice drug test guide: which panels detect it, urine/hair/saliva/blood detection windows, cutoff levels and prescription verification. Full guide →

How Long Does K2/Spice Stay in Urine?

How long K2/Spice stays detectable in urine — urine, hair, saliva & blood windows explained with cutoffs. Full guide →

How accurate are drug tests?

Lab-based immunoassay screens agree with confirmation testing ~97% of the time; confirmed GC–MS results are considered definitive. Home kits trade legal defensibility for convenience.

Do prescriptions count against me?

No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.

Sources & further reading

  • SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
  • DOT — 49 CFR Part 40 procedures for transportation workplace testing
  • Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
  • FDA — drug-of-abuse test device labeling (detection window conventions)